Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Total Liabilities: 2010-2025

Historic Total Liabilities for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $58.8 million.

  • ProPhase Labs' Total Liabilities rose 9.61% to $58.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.8 million, marking a year-over-year increase of 9.61%. This contributed to the annual value of $55.8 million for FY2024, which is 31.27% up from last year.
  • As of Q3 2025, ProPhase Labs' Total Liabilities stood at $58.8 million, which was up 92.26% from $30.6 million recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Total Liabilities peaked at $58.8 million during Q3 2025, and registered a low of $24.0 million during Q4 2022.
  • Over the past 3 years, ProPhase Labs' median Total Liabilities value was $42.5 million (recorded in 2023), while the average stood at $43.1 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 2,549.88% in 2021, then crashed by 38.30% in 2025.
  • Over the past 5 years, ProPhase Labs' Total Liabilities (Quarterly) stood at $30.7 million in 2021, then decreased by 21.68% to $24.0 million in 2022, then surged by 77.14% to $42.5 million in 2023, then soared by 31.27% to $55.8 million in 2024, then increased by 9.61% to $58.8 million in 2025.
  • Its last three reported values are $58.8 million in Q3 2025, $30.6 million for Q2 2025, and $35.0 million during Q1 2025.